GLOBAL BLARCAMESINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2031)
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer\\\'s Disease, Parkinson\\\'s Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
On November 20, 2023, Anavex Life Sciences, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, announced that the company has initiated a regulatory submission of oral blarcamesine for Alzheimer’s disease to the European Medicines Agency (EMA).